Goodman and Recursion have formed a collaboration that is generating payments and undergoing regulatory review for drug development.

The entities involved

• Goodman →

  Japanese company

  • Local councils in Sydney are demanding tougher national regulations as companies seek social license amid rising real estate prices driven by power supply needs.Sun 10:57
• Recursion (United States) →

  company in Salt Lake City, United States

  • Recursion (United States) disclosed insider trading via required filings with the SEC on June 6, 2026.Sun 17:12
  • Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.Sun 05:14
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• FDA approval supports commercial partner contracts for Vericel.Sep 22
• Approval leads to procurement process initiation.Sep 18
• Collaboration revenue from GSK increased total revenue, and FDA action is needed for tepipenem HBR approval.Jun 7
• The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.Sep 17
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7